REGN
Regeneron·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
REGN Filings
Filing Date
Form Description
Form Type
2025-11-24
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-24 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-24
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-24 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-20
Form 144 - Report of proposed sale of securities
Ownership
2025-11-20 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-10
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-10 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-07
Form 144 - Report of proposed sale of securities
Ownership
2025-11-07 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-07
Form 13F-HR - Quarterly report filed by institutional managers, Holdings
Ownership
2025-11-07 · Ownership
Form 13F-HR - Quarterly report filed by institutional managers, Holdings
2025-10-31
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-31 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-31
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-31 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-29
Form 144 - Report of proposed sale of securities
Ownership
2025-10-29 · Ownership
Form 144 - Report of proposed sale of securities
2025-10-28
Regeneron Pharmaceuticals, Inc. (REGN) Q3 2025 Earnings Call Transcript
Earnings Call
2025-10-28 · Earnings Call
Regeneron Pharmaceuticals, Inc. (REGN) Q3 2025 Earnings Call Transcript
